Experience

Oyster Point Pharma to Be Acquired by Viatris

November 10, 2022

Cooley advised Oyster Point Pharma, a top ophthalmology-focused biopharmaceutical company, on its definitive agreement to be acquired by global healthcare company Viatris. Partners Mika Reiner Mayer, Brandon Fenn, Div Gupta and Ian Nussbaum led the Cooley team advising Oyster Point Pharma.

Read more

Related contacts

Mika Reiner Mayer
Partner, Palo Alto
Brandon W. Fenn
Partner, New York
Div Gupta
Partner, New York
Sarah Lightdale
Partner, New York
Eileen Marshall
Partner, Washington DC
Howard Morse
Partner, Washington DC
John Paul Oleksiuk
Partner, New York
Nyron J. Persaud
Partner, New York
John Robertson
Partner in Charge – Seattle, Seattle
Natasha Leskovsek
Of Counsel, Washington DC
Ryan Montgomery
Special Counsel, Boston
Thomas Welk
Senior Counsel, San Diego
Nathan Baum
Associate, New York
Kimberly Bolin
Patent Agent, Palo Alto
Julia R. Brinton
Associate, Washington DC
Cara Buchicchio
Associate, New York
Colette Ghazarian
Associate, Los Angeles Downtown
Liz Gold
Associate, New York
Edward (Teddy) Nimetz
Associate, New York
Ryan Walker
Associate, New York